Boston Scientific (BSX) Tops Q2 EPS by 3c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.98 -5.9%
Revenue Growth %: +3.7%
Financial Fact:
Restructuring charges: 5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.7%
Financial Fact:
Restructuring charges: 5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.40, $0.03 better than the analyst estimate of $0.37. Revenue for the quarter came in at $3.08 billion versus the consensus estimate of $2.94 billion.
GUIDANCE:
Boston Scientific sees FY2021 EPS of $1.58-$1.62, versus the consensus of $1.58.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
- Braze stock tumbles 10% on weak third quarter EPS guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
